Direct HIV cytopathicity cannot account for CD4 decline in AIDS in the presence of homeostasis: A worst-case dynamic analysis

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 17, Issue 3, 1998, Pages 245-252

  Anderson, Russell W ^a,b   Ascher, Michael S ^b   Sheppard, Haynes W ^b  

^a SMITH KETTLEWELL EYE RESEARCH INSTITUTE   (United States)

^b VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

Author keywords

AIDS; Apoptosis; Cytopathic hypothesis; HIV dynamics; HlV; Immune activation; Lymphocyte dynamics; Pathogenesis; Tap and drain model

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; CELL DEATH; CELL MIGRATION; CYTOPATHOGENIC EFFECT; DISEASE COURSE; DYNAMICS; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MATHEMATICAL MODEL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0032032504     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199803010-00010     Document Type: Article

References (96)

1. Lee TH, Sheppard HW, Reis M, Dondero D, Osmond D, Busch MP. Circulating HIV 1-infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course. J Acquir Immune Defic Svndr Hum Retrovirol 1994;7: 381-8.
2. Mellors J, Rinaldo C, Gupta P, White R, Todd J, Kingsley L. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
3. Sheppard HW, Lang W, Ascher MS, Vittinghoff E, Winkelstein W. The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS 1993;7:1159-66.
4. Phillips AN, Elford J, Sabin C, Janossy G, Lee CA. Pattern of CD4+ T cell loss in HIV infection. J Acquir Immun Defic Syndr 1992;5:950-1.
5. Lang W, Perkins H, Andersen RE, Royce R, Jewell N, Winklestein W. Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immun Defic Syndr 1989;2:63-9.
6. Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 1986;322:470-4.
7. Lifson JD, Reyes GR, McGrath MS, Stein BS, Engleman EG. AIDS retrovirus induced cytopathology: Giant cell formation and involvement of CD4 antigen. Science 1986;232:1123-6.
8. Lemaitre M, Guerard D, Henin Y, Montagnier L, Zerial A. Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency virus in CEM cells. Res Virol 1990;141:5-13.
9. Tersmette M, Schuitemaker H. Virulent HIV strains? AIDS 1993; 7:1123-25.
10. Short N. A fight to the death. Nature 1995;1:122-4.
11. Ho D. Viral counts count in HIV infection. Science 1996;272: 1124-5.
12. Stein DS, Drusano GL. Modeling of the change in CD4 lymphocyte counts in patients before and after administration of the Human Immunodeficiency Virus protease inhibitor indinavir. Antimicrob Agents Chemother 1997;41:449-53.
13. Amadori A, Zamarchi R, bianchi L. CD4:CD8 ratio and HIV infection: "the Tap-and-drain" hypothesis. Immunol Today 1996;414-7.
14. Hoxie JA, Haggarty BS, Rackowski JL, Pillsbury N, Levy JA. Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus. Science 1985;229:1400-2.
15. Zolla-Pazner S. Immunologic abnormalities in infections with the human immunodeficiency virus. Lab Med 1986;17:685-9.
16. Rosenberg ZF, Fauci AS. Immunopathologic mechanisms of HIV infection. Clin Immunol 1989;S149-56.
17. Langhoff E, McElrath J, Bos HJ, et al. Most CD4+ T cells from human immunodeficiency virus-1 infected patients can undergo prolonged clonal expansion. J Clin Invest 1989;84:1637-43.
18. Lo SC, Tsai S, Benish JR, Shih JWK, Wear DJ, Wong DM. Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma. Science 1991;251:1074-76
19. Mosier DE, Gulizia RJ, MacIsaac PD, Torbett BE, Levy JA. Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates. Science 1993;260:689-92.
20. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993;57:183-289.
21. Zinkernagel RM. Virus-triggered AIDS: a T-cell-mediated immunopathology? Immunol Today 1988;9:370-2.
22. Finkel TH, Banda NK. Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells? Curr Opin Immunol 1994;6:605-15.
23. Finkel TH, Tudor-Williams G, Banda NK, et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med 1995;1: 129-34.
24. Finkel TH, Monks C, Casella C, et al. Apoptosis and HIV disease: reply. Nat Med 1995;1:387.
25. Wolthers KC, Wisman GBA, Otto SA, et al. T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science 1996;274:1543-47.
26. Ascher MS, Sheppard HW. AIDS as immune system activation: a model for pathogenesis. Clin Exp Immunol 1988;73:165-7.
27. Ascher MS, Sheppard HW. AIDS as immune system activation II: the panergic imnesia hypothesis. J Acquir Immune Defic Syndr 1990;3:177-91.
28. Sheppard HW, Ascher MS, Krowka JF. Viral burden and HIV disease. Nature 1993;364:291.
29. Piatak M, Saag MS, Yang LC, Clark SJ, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-54.
30. Layne SP, Merges MJ, Dembo M, et al. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 1992;189:695-714.
31. Dimitrov DS, Willey RL, Sato H, Chang LJ, Blumenthal R, Martin MA. Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virol 1993;67:2182-90.
32. Dimitrov D, Martin MA. HIV results in the frame: CD4 cell turnover. Nature 1995;375:194-5.
33. Schnittman SM, Psallidopoulos MC, Lane HC, et al. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 1989;245:305-8.
34. Schnittman SM, Greenhouse JJ, Psallidopoulos MC, et al. Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med 1990; 113:438-43.
35. Simmonds P, Balfe P, Peutherer JF, Ludlam CA, Bishop JO, Brown AJL. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol 1990;64:864-72.
36. Sheppard HW, Ascher MS. The natural history and pathogenesis of HIV infection. Annu Rev Microbiol 1992;46:533-64.
37. Chun TW, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997;387:183-8.
38. Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature 1997;387:188-191.
39. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.
40. Haase AT, Henry K, Zupancic M, et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996;274: 985-9.
41. Ascher MS, Sheppard HW, Krowka JF, Bremermann HJ. Aids as immune system activation: key questions that remain. In Andrieu J-M, Lu W, eds. Cell activation and apoptosis in HIV infection. New York: Plenum Press, 1995: 203-10.
42. Ascher MS, Sheppard HW, Anderson RW, Krowka JF, Bremermann HJ. Paradox remains. Nature 1995;375:196.
43. Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
44. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
45. Wain-Hobson S. Virological mayhem. Nature 1995;373:102.
46. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995;267: 483-9.
47. Grossman V, Herberman RB. T-cell homeostasis in HIV infection is neither failing nor blind: modified cell counts reflect an adaptive response of the host. Nat Med 1997;3:486-90.
48. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell lifespan, and viral generation time. Science 1996;271:1582-6.
49. Ballem PJ, Belzberg A, Devine DV, et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med 1992;327:1779-84.
50. Wain-Hobson S. Down or out in blood and lymph? Nature 1997; 387:123-4.
51. Mosier D. HIV results in the frame: CD4 cell turnover. Nature 1995;375:193-4.
52. Sprent J, Tough D. HIV results in the frame: CD4 cell turnover. Nature 1995;375:194.
53. Cohen J. Researchers air alternative views on how HIV kills cells. Science 1995;269:1044-5.
54. Levy JA, Ramachandran B, Baker E. Plasma viral load, CD4 cell counts, and HIV-1 production by cells. Science 1996;271:670-1.
55. Grossman Z, Bentwich Z, Herberman RB. From HIV infection to AIDS: are the manifestations of effective immune resistance misinterpreted? Clin Immunol Immunopathol 1993;69:1-13.
56. Wood R, Dong H, Katzenstein DA, Merigan TC. Quantification and comparison of HIV-1 proviral load in peripheral blood mononuclear cells and isolated CD4+ T cells. J Acquir Immune Defic Syndr 1993;6:237-40.
57. Yerly S, Chamot E, Hirschel B, Perrin LH. Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters. J infect Dis 1992;166:269-76.
58. Innocenti P, Ottmann M, Morand P, Leclerq P, Seigneurin JM. HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count. AIDS Res Hum Retroviruses 1992;8:261-8.
59. Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993;362:359-62.
60. Freitas AA, Rocha BB. Lymphocyte lifespans: homeostasis, selection and competition. Immunol Today 1993;14:25-9.
61. Cunnane G, O'Farrelly C. Regeneration of T cells after chemotherapy[letter]. New Engl J Med 1995;332:1650-1.
62. Machleder HI, Paulus H. Clinical and immunological alterations observed in patients undergoing long-term thoracic duct drainage. Surgery 1978;84:157-65.
63. Horneff G, Burmester GR, Emmrich F, Kalden JR. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum 1991;34:129-40.
64. Horneff G, Emmrich F, Burmester GR. Advances in immunotherapy of rheumatoid arthritis: clinical and immunological findings following treatment with anti-CD4 antibodies. Br J Radiol 1993;32:39-47.
65. Tough DF, Sprent J. Turnover of naive- and memory-phenotype T cells. J Exp Med 1994;179:1127-35.
66. Karsh J, Wright DG, Klippel JH, et al. Lymphocyte depletion by continuous flow cell centrifugation in rheumatoid arthritis. Arthitis Rheum 1979;22:1055-9.
67. Wright DG, Karsh J, Fauci AS, et al. Lymphocyte depletion and immunosuppression with repeated leukapheresis by continuous flow centrifugation. Blood 1981;58:3.
68. Young AJ, Hay JB. Rapid turnover of the recirculating lymphocyte pool in vivo. Int Immunol 1995;7:1607-15.
69. Katsikis PD, Garcia-Ojeda ME, Torres-Roca JF, et al. Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection. J Exp Med 1997;186:1365-72.
70. Donnenberg AD, Margolick JF, Beltz LA, Donnenberg VS, Rinaldo CR. Apoptosis parallels lymphopoiesis in bone marrow transplantation and HIV disease. Res Immunol 1995;146:11-21.
71. Pandolfi F, Pierdominici M, Oliva A, et al. Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:450-8.
72. Roederer M. T-cell dynamics of immunodeficiency. Nat Med 1995;1:621-2.
73. Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996;173:321-9.
74. Bisset LR, Rothen M, Joller-Jemelka HI, Dubs RW, Grob PJ, Opravil M. Change in circulating levels of the chemokines macrophage inflammatory proteins 1alpha and 1beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir. AIDS 1997;11:485-91.
75. Lambert JS, Mofenson LM, Fletcher CV, et al. Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. J Infect Dis 1997;175:283-91.
76. Pantaleo G, Fauci AS. Apoptosis in HIV infection. Nature 1995; 1:118-20.
77. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F. Programmed death of T cells in HIV-1 infection. Science 1992;257:217-9.
78. Tanchot C, Rocha B. The peripheral T cell repertoire: independent homeostatic regulation of virgin and activated CD8+ T cell pools. Eur J Immunol 1995;25:2127-36.
79. Margolick JB, Munoz A, Donnenberg AD, et al. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. Nature Med 1995;1:674-80.
80. McLean A, Michie C. Viral burden in AIDS. Nature 1993;365: 301.
81. Moreland LW, Bucy RP, Koopman WJ. Regeneration of T cells after chemotherapy. New Engl J Med 1995;332:1651-52.
82. Tough DF, Sprent J. Lifespan of lymphocytes. Immunol Res 1995; 14:1-12.
83. McDonagh M, Bell EB. The survival and turnover of mature and immature CD8 T cells. Immunology 1995;84:514-20.
84. Nowak MA, Anderson RM, McLean AR, Wolfs TFW, Goudsmit J, May RM. Antigenic diversity thresholds and the development of AIDS. Science 1991;254:963-9.
85. Perelson AS, Kirschner DE, De Boer R. Dynamics of HIV infection of CD4+ T cells. Math Biosci 1993;114:81-125.
86. Merrill SJ, Radke RJ. A stochastic model of the generation of diversity in HIV infection. Dept. of Mathematics, Marquette Univ: 1995;1-32
87. Roederer M. T-cell dynamics of immunodeficiency. Nat Med 1995;1:621-2.
88. Sheppard HW, Ascher MS. The relationship between AIDS and immunologic tolerance. J Acquir Immune Defic Syndr 1992;5: 143-7.
89. Ho DD, Perelson AS, Shaw GM. HIV results in the frame: Reply. Nature 1995;375:198.
90. Cavert W, Notermans DW, Staskus K, et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997;276:960-4.
91. Habeshaw JA, Dalgleish AG. The relevance of HIV env/CD4 interactions to the pathogenesis of acquired immune deficiency syndrome. J Acquir Immune Defic Syndr 1989;2:457-68.
92. Dalgleish AG. The immune response to HIV: potential for immunotherapy? Immunol Today 1995;16:356-8.
93. Ameisen JC, Capron A. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today 1991;12: 102-5.
94. Hoffmann GW. C0-selection in immune network theory and in AIDS pathogenseis Immunol Cell Biol 1994;72:338-46.
95. Miedema F, Tersmette M, van Lier RAW. AIDS pathogenesis: a dynamic interaction between HIV and the immune system. Immunol Today 1990;11:293-7.
96. Anderson RW. Mathematical models of HIV pathogenesis. Nat Med 1997;3:936-7.